Examining biofilm in arterial catheters in ICU patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the structural and microbiological aspects of biofilm that forms on arterial catheters used in ICU patients. By utilizing optical coherence tomography, the researchers will gather data to understand the relationship between biofilm formation and the incidence of bacteremias associated with these vascular devices. The goal is to provide insights that could lead to improved prevention strategies or targeted treatments for infections related to arterial catheters.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient or relative informed of the study and having declared their non-objection
* Patient over 18 years old
* Patient hospitalized in ICU with an arterial catheter

Exclusion Criteria:

* Patient unable to express consent
* Patient whose collection of the arterial catheter is impossible or for whom storage at 4°C is impossible
* Patient with arterial catheter removed outside the usual procedure of the ICU
* Patient admitted in ICU with an arterial catheter already in place

Where it's running

• CHU Dijon Bourgogne
  Dijon, Bourgogne-Franche-Comté, France Recruiting
• CH Macon
  Mâcon, Bourgogne-Franche-Comté, France Recruiting

Study contacts

• Study coordinator: Florian PERRAUD
• Email: florian.perraud@ch-chalon.fr
• Phone: 06 78 58 85 19

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UllCORE BSI Test for Bloodstream Infections

  This study tests whether the UllCORE BSI Test can correctly detect bloodstream infection pathogens and resistance markers from whole blood in people with suspected infection or sepsis.

  Recruiting Deepull Diagnostics S.L. · Orange, California and 19 other locations · NCT07859852

• Beta-lactam plus levofloxacin for streptococcal bacteremia

  This trial tests whether adding levofloxacin to standard beta-lactam therapy helps adults with streptococcal bacteremia see better outcomes.

  Recruiting at 2 sites Phase 4 Mahidol University · Bangkok and 3 other locations · NCT07240077

• Blood cultures from arterial lines: does it change contamination, bacteremia detection, and how much blood is drawn?

  This study tests whether drawing blood cultures from arterial lines affects contamination rates, how well bacteremia is detected, and the volume of blood collected in ICU patients.

  Recruiting Meir Medical Center · Kfar Saba · NCT07183410

• New care guideline for infants 60 days and younger with fever in Sweden

  This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.

  Recruiting at 9 sites Region Skane · Gothenburg and 10 other locations · NCT07134751

• GRADY: a computer tool to detect early sepsis and gram-negative bloodstream infection in ICU patients

  The GRADY tool will be tested to see if routine vital signs and lab results can detect early sepsis and gram-negative bloodstream infection in adult ICU patients.

  Recruiting Sisli Hamidiye Etfal Training and Research Hospital · Seyrantepe, Istanbul · NCT07126106

• Choriocapillaris blood flow differences in people with pseudoxanthoma elasticum versus healthy adults

  We will test whether a noninvasive eye scan (OCT angiography) shows reduced choriocapillaris blood flow in adults with pseudoxanthoma elasticum compared with matched healthy adults.

  Recruiting University Hospital, Angers · Angers · NCT07006649

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.